CONTACT US:
    (805) 483 1185

All fields are required.

Close Appointment form

    CONTACT US:
    (805) 483 1185

    Moderna to begin Phase 3 of COVID-19 vaccine study in July

    • Home
    • Moderna to begin Phase 3 of COVID-19 vaccine study in July
    Moderna to begin Phase 3 of COVID-19 vaccine study in July
    Moderna to begin Phase 3 of COVID-19 vaccine study in July

    No Comments

    Moderna to begin Phase 3 of COVID-19 vaccine study in July

    Modern to begin COVID-19 vaccine study in July 2020

    Moderna (NSDQ:MRNA) announced today that it expects to begin dosing in Phase 3 of the clinical trial for its COVID-19 vaccine candidate in July.

    The Cambridge, Mass.-based biotech company said in a news release that it finalized the Phase 3 study protocol for the mRNA-1273 COVID-19 vaccine candidate based on feedback from the FDA. The randomized, 1:1 placebo-controlled trial is expected to include approximately 30,000 enrolled U.S. participants in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

    Source – https://www.drugdiscoverytrends.com/moderna-to-begin-phase-3-of-covid-19-vaccine-study-in-july/

    • Share This

    Related Posts

    Submit a comment

    Your email address will not be published. Required fields are marked *

    Leave a Reply

    You may use these HTML tags and attributes:

    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>